Abstract:AbstractBackgroundSubcutaneous and visceral adipose tissues are important body components, but their effects on the mortality in patients with liver cirrhosis remain controversial based on the current evidence.MethodsWe retrospectively identified 372 eligible patients in whom subcutaneous adipose tissue index (SATI) and visceral adipose tissue index (VATI) could be measured by computed tomography images at the third lumbar vertebra. The association of SATI and VATI with the risk of death was evaluated on a continuous scale with restricted cubic spline curves based on Cox proportional hazards models. Cumulative probability of mortality was estimated by Nelson–Aalen cumulative risk curve analyses. Independent predictors of death were evaluated by competing risk analyses after adjusting for age, sex, and model for end‐stage liver disease score.ResultsMajority of patients were male (69.4%) with a mean age of 55.40 ± 10.68 years. SATI had a U‐shaped association with mortality (P for non‐linearity <0.001). Cutoff values of SATI were 19.7 and 51.8 cm2/m2 at the points where hazard ratios were just <1.2. SATI was categorized as low (<19.7 cm2/m2), moderate (19.7–51.8 cm2/m2), and high (>51.8 cm2/m2) level. There was no significant difference in the cumulative probability of mortality between low versus moderate SATI groups (Gray's test, P = 0.052) and high versus moderate SATI groups (Gray's test, P = 0.054). Competing risk analyses demonstrated that low SATI could increase the mortality compared with moderate SATI (subdistribution hazard ratio [sHR] = 1.66, 95% confidence interval [CI]: 0.992–2.78, P = 0.054) and was an independent predictor of death (sHR = 1.86, 95% CI: 1.059–3.28, P = 0.031). Competing risk analyses also demonstrated that high SATI could significantly increase the mortality compared with moderate SATI (sHR = 1.6, 95% CI: 1–2.54, P = 0.049), and was an independent predictor of death (sHR = 2.007, 95% CI: 1.195–3.37, P = 0.0085). VATI had an irregularly shaped association with mortality (P for non‐linearity <0.001). Cutoff values of VATI were 9.8 and 40.2 cm2/m2 at the points where hazard ratios were just <1.2. VATI was categorized as low (<9.8 cm2/m2), moderate (9.8–40.2 cm2/m2), and high (>40.2 cm2/m2) level. There was no significant difference in the cumulative probability of mortality between low versus moderate VATI groups (Gray's test, P = 0.381) and high versus moderate VATI groups (Gray's test, P = 0.787). Competing risk analyses demonstrated that neither low (sHR = 1.27, 95% CI: 0.599–2.7, P = 0.53) nor high VATI (sHR = 0.848, 95% CI: 0.539–1.34, P = 0.48) was an independent predictor of death compared with moderate VATI.ConclusionsBoth excessive deficiency and accumulation of subcutaneous adipose tissues negatively influence the outcomes of cirrhotic patients.

High Visceral Adipose Tissue Density Correlates with Unfavorable Outcomes in Patients with Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

The Influence of Visceral Adiposity on Overall Survival: Exploring "Obesity Paradox" Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy

Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis

Body Composition Changes in Hepatocellular Carcinoma: Prediction of Survival to Transcatheter Arterial Chemoembolization in Combination With Clinical Prognostic Factors

Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis

Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series.

The value of quantitative CT body composition analysis in prediction of prognosis in patients with hepatic cell carcinoma treated with transcatheter arterial chemoembolization

Prognostic Impact of Visceral Adipose Tissue Imaging Parameters in Patients with Cholangiocarcinoma after Surgical Resection

High Visceral Adipose Tissue Area is Independently Associated with Early Allograft Dysfunction in Liver Transplantation Recipients: a Propensity Score Analysis

Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma.

U‐shaped Relationship Between Subcutaneous Adipose Tissue Index and Mortality in Liver Cirrhosis

Survival prediction of hepatocellular carcinoma by measuring the extracellular volume fraction with single-phase contrast-enhanced dual-energy CT imaging

The Density of Cancer-Associated Fibroblasts As A Prognostic Indicator for Hepatocellular Carcinoma.

Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy

AST-to-APOA Ratio to Predict Overall Survival in Hepatocellular Carcinoma Receiving TACE.

High Epithelial Cell Adhesion Molecule–Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization

Visceral adipose tissue in predicting survival in patients with advanced colorectal cancer

Different Impacts of Adipose Tissue Dynamics on Prognosis in Patients with Resectable Locally Advanced Rectal Cancer Treated with and Without Neoadjuvant Treatment

The preliminary study of volumetric CT measurement in the prognostic evaluation of patients with advanced primary liver carcinoma treated by transcatheter arterial chemoembolization

The Therapeutic Effect of Transcatheter Arterial Thromboembolization of Hepatocellular Carcinoma As for Residual Viable Tumors Related to Lipoidal Density Areas and Detected by (18)F-FDG PET/CT and CT.